Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Hematology · Myelodysplastic Syndromes

Recognizing the Symptoms of MDS

At a Glance

MDS symptoms are caused by a lack of healthy blood cells. The most common warning signs include intense fatigue from anemia, easy bruising or tiny red spots (petechiae) from low platelets, and frequent infections from low white blood cells.

When you have Myelodysplastic Syndromes (MDS), your symptoms are rarely a mystery—they are usually a direct reflection of what is happening in your bone marrow. Because MDS disrupts the production of healthy blood cells, the physical “warning signs” you feel depend on which type of blood cell is in short supply [1][2].

This guide helps you connect your physical experiences to the underlying biology of the disease.

Symptoms Driven by Low Blood Counts

The medical term for low blood counts is cytopenia [3]. Depending on which “line” of cells is affected, you may experience different groups of symptoms:

1. Anemia (Low Red Blood Cells)

Red blood cells carry oxygen to your organs. When they are low, your body essentially runs on low fuel. This is the most common symptom of MDS [4].

  • What it feels like: Intense fatigue that doesn’t go away with rest, shortness of breath during light activity (like walking to the mailbox), and heart palpitations [5][2].
  • Overlooked sign: Feeling dizzy or lightheaded when standing up quickly.

2. Thrombocytopenia (Low Platelets)

Platelets are the cells that help your blood clot. Without enough of them, you may bleed or bruise more easily than usual [2].

  • What it feels like: Frequent nosebleeds, bleeding gums after brushing your teeth, or heavy menstrual cycles.
  • Overlooked sign: Petechiae, which are tiny, flat red or purple spots on the skin (often on the lower legs) that look like a rash but do not itch or fade when pressed [6].

3. Neutropenia (Low White Blood Cells)

White blood cells (neutrophils) are your body’s primary defense against infection.

  • What it feels like: You may not “feel” neutropenia itself, but you may notice you are getting sick more often [7].
  • Overlooked sign: Because you lack white blood cells to mount a typical inflammatory response, minor cuts or localized infections may not become red, swollen, or form pus [8]. Waiting for classic redness can dangerously delay treatment. You must be vigilant for localized pain, warmth, or running “low-grade” fevers for no apparent reason [7].

Systemic and “Hidden” Symptoms

MDS is increasingly viewed as a disease of immune dysregulation, meaning the immune system itself may become overactive or confused [9].

  • Inflammatory Issues: Some patients experience joint pain, skin rashes, or “flu-like” symptoms that aren’t caused by a virus [10][11].
  • Iron Overload: If you receive frequent blood transfusions, your body may accumulate too much iron. This can cause its own symptoms, such as joint pain, abdominal pain, or a darkening of skin color [12][13].

Conditions That “Mimic” MDS

It is important to know that several non-cancerous conditions can cause blood counts and symptoms that look exactly like MDS. Doctors must carefully rule these out:

  • Nutritional Deficiencies: A severe Vitamin B12 deficiency or copper deficiency can make bone marrow look “dysplastic” (abnormal) under a microscope [14].
  • Autoimmune Disorders: Conditions where the body attacks its own blood cells can mimic the low counts seen in MDS [15].
  • VEXAS Syndrome: A recently discovered inflammatory condition that can look very similar to MDS in its early stages [16].

Variability and Progression

In lower-risk MDS, you may only have one low cell line (usually red blood cells) and symptoms may remain stable for years [17]. In higher-risk MDS, it is more common to have pancytopenia—where all three cell lines are low—leading to a combination of fatigue, bruising, and infections [18][4]. If you notice your symptoms are suddenly worsening, it may indicate a shift in the disease that requires a new evaluation.

Common questions in this guide

Why do I feel so tired with MDS?
The severe fatigue in MDS is usually caused by anemia, which happens when you have low red blood cells. Without enough red blood cells, your body cannot deliver adequate oxygen to your organs and muscles, leaving you exhausted even after resting.
What are petechiae and what do they look like?
Petechiae are tiny, flat red or purple spots on the skin that look like a rash but do not itch or fade when you press on them. They often appear on the lower legs and are a sign that your body is not making enough platelets.
Why might my infections look different with MDS?
If your white blood cell count is very low, your body cannot mount a typical inflammatory response. This means minor cuts or infections might not become red, swollen, or form pus like they normally would, so you must watch for pain or low-grade fevers instead.
Can MDS cause joint pain or rashes?
Yes, some people with MDS experience joint pain, skin rashes, or flu-like symptoms. This can happen because the disease causes immune dysregulation, meaning your immune system becomes overactive or confused.
Could my MDS symptoms actually be something else?
Yes, several non-cancerous conditions can cause low blood counts that mimic MDS. Severe Vitamin B12 deficiency, copper deficiency, and certain autoimmune disorders can look identical to MDS and must be carefully ruled out by your doctor.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Which specific blood cell lines—red cells, white cells, or platelets—are currently low in my case?
  2. 2.How do my current blood counts explain the symptoms I am feeling, like this specific type of fatigue or bruising?
  3. 3.Have we ruled out 'mimic' conditions like Vitamin B12 deficiency, copper deficiency, or recent viral infections?
  4. 4.Could any of my 'non-blood' symptoms, such as joint pain or skin rashes, be related to immune dysregulation from MDS?
  5. 5.Should I be monitoring for 'red flag' symptoms like a fever or night sweats, and when should I call you immediately?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (18)
  1. 1

    Myelodysplastic syndromes: 2021 update on diagnosis, risk stratification and management.

    Garcia-Manero G, Chien KS, Montalban-Bravo G

    American journal of hematology 2020; (95(11)):1399-1420 doi:10.1002/ajh.25950.

    PMID: 32744763
  2. 2

    Outpatient transfusions for myelodysplastic syndromes.

    Wood EM, McQuilten ZK

    Hematology. American Society of Hematology. Education Program 2020; (2020(1)):167-174 doi:10.1182/hematology.2020000103.

    PMID: 33275745
  3. 3

    Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Consortium for MDS (icMDS).

    Stahl M, Bewersdorf JP, Xie Z, et al.

    Blood reviews 2023; (62()):101128 doi:10.1016/j.blre.2023.101128.

    PMID: 37704469
  4. 4

    Karyotype evolution and acquisition of FLT3 or RAS pathway alterations drive progression of myelodysplastic syndrome to acute myeloid leukemia.

    Meggendorfer M, de Albuquerque A, Nadarajah N, et al.

    Haematologica 2015; (100(12)):e487-90 doi:10.3324/haematol.2015.127985.

    PMID: 26294738
  5. 5

    Health-related quality of life in lower-risk MDS patients compared with age- and sex-matched reference populations: a European LeukemiaNet study.

    Stauder R, Yu G, Koinig KA, et al.

    Leukemia 2018; (32(6)):1380-1392 doi:10.1038/s41375-018-0089-x.

    PMID: 29572506
  6. 6

    From Histiocytoid Sweet Syndrome to Myelodysplasia Cutis: History and Perspectives.

    Vignon-Pennamen MD, Battistella M

    Dermatologic clinics 2024; (42(2)):209-217 doi:10.1016/j.det.2023.08.004.

    PMID: 38423682
  7. 7

    Infectious complications in patients with myelodysplastic syndromes: A review of the literature with emphasis on patients treated with 5-azacitidine.

    Radsak M, Platzbecker U, Schmidt CS, et al.

    European journal of haematology 2017; (99(2)):112-118 doi:10.1111/ejh.12883.

    PMID: 28321924
  8. 8

    Supportive Care for Patients With Myelodysplastic Syndromes.

    Stempel JM, Podoltsev NA, Dosani T

    Cancer journal (Sudbury, Mass.) 2023; (29(3)):168-178 doi:10.1097/PPO.0000000000000661.

    PMID: 37195773
  9. 9

    Immune Dysregulation and Recurring Mutations in Myelodysplastic Syndromes Pathogenesis.

    Matos A, Magalhães SMM, Rauh MJ

    Advances in experimental medicine and biology 2021; (1326()):1-10 doi:10.1007/5584_2020_608.

    PMID: 33385175
  10. 10

    Myelodysplastic syndrome and autoimmune disorders: two sides of the same coin?

    Hochman MJ, DeZern AE

    The Lancet. Haematology 2022; (9(7)):e523-e534 doi:10.1016/S2352-3026(22)00138-7.

    PMID: 35772431
  11. 11

    Incidence of and risk factors for myelodysplastic syndrome in patients with rheumatologic diseases.

    Kim YE, Ahn SM, Oh JS, et al.

    Rheumatology (Oxford, England) 2024; (63(5)):1305-1312 doi:10.1093/rheumatology/kead374.

    PMID: 37498607
  12. 12

    Clinical features and outcomes of myelodysplastic syndrome patients with iron overload: a single-center retrospective study.

    Huang L, Wang Y, Zhang X, et al.

    European journal of medical research 2025; (30(1)):600 doi:10.1186/s40001-025-02848-1.

    PMID: 40635108
  13. 13

    Iron overload in myelodysplastic syndromes: Evidence based guidelines from the Canadian consortium on MDS.

    Leitch HA, Buckstein R, Zhu N, et al.

    Leukemia research 2018; (74()):21-41 doi:10.1016/j.leukres.2018.09.005.

    PMID: 30286330
  14. 14

    Hematogones Detected by Flow Cytometry in a Child with Vitamin B12 Deficiency.

    Sutton L, Mba N

    Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society 2017; (20(2)):172-175 doi:10.1177/1093526616686241.

    PMID: 28326965
  15. 15

    [Myelodysplastic syndromes and autoimmunity].

    Stalder G, Alberio L, Ribi C

    Revue medicale suisse 2015; (11(469)):820-2, 824-5.

    PMID: 26040163
  16. 16

    Myelodysplasia cutis and VEXAS syndrome initially diagnosed as histiocytoid Sweet syndrome: A diagnostic pitfall.

    Shimshak SJ, Jasmine S, Davis MDP, et al.

    Journal of cutaneous pathology 2024; (51(11)):834-839 doi:10.1111/cup.14678.

    PMID: 38993097
  17. 17

    Updates on risk stratification and management of lower-risk myelodysplastic syndromes/neoplasms.

    Badar T, Madanat YF, Zeidan AM

    Future oncology (London, England) 2023; (19(27)):1877-1889 doi:10.2217/fon-2023-0454.

    PMID: 37750305
  18. 18

    Current State of the Art: Management of Higher Risk Myelodysplastic Syndromes.

    Komrokji RS

    Clinical lymphoma, myeloma & leukemia 2016; (16 Suppl()):S39-43.

    PMID: 27521322

This page provides educational information about MDS symptoms. Always consult your hematologist or healthcare provider for medical advice, accurate diagnosis, and symptom management.

Get notified when new evidence is published on Myelodysplastic syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.